PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers
Authors
Keywords
-
Journal
ONCOGENE
Volume 38, Issue 40, Pages 6662-6677
Publisher
Springer Science and Business Media LLC
Online
2019-08-07
DOI
10.1038/s41388-019-0908-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The nutrient environment affects therapy
- (2018) Alexander Muir et al. SCIENCE
- Temporal dynamics of Wnt-dependent transcriptome reveal an oncogenic Wnt/MYC/ribosome axis
- (2018) Babita Madan et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
- (2017) Tyler E. Miller et al. NATURE
- Drugging RAS: Know the enemy
- (2017) Bjoern Papke et al. SCIENCE
- A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
- (2017) Grace R. Anderson et al. Cell Reports
- Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy
- (2017) Vincent Chung et al. JAMA Oncology
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- (2016) Pascal Hammel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Positive Breast Cancer
- (2016) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition
- (2016) Babita Madan et al. Oncotarget
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma
- (2015) A. H. Ko et al. CLINICAL CANCER RESEARCH
- Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.
- (2015) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract C45: Phase I study of WNT974, a first-in-class Porcupine inhibitor, in advanced solid tumors
- (2015) Filip Janku et al. MOLECULAR CANCER THERAPEUTICS
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling
- (2015) Ruiting Lin et al. NATURE CELL BIOLOGY
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
- (2014) K. T. Pate et al. EMBO JOURNAL
- A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
- (2014) Jeffrey R. Infante et al. EUROPEAN JOURNAL OF CANCER
- Integrated Stability and Activity Control of theDrosophilaRbf1 Retinoblastoma Protein
- (2014) Liang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parallel In Vivo and In Vitro Melanoma RNAi Dropout Screens Reveal Synthetic Lethality between Hypoxia and DNA Damage Response Inhibition
- (2014) Patricia A. Possik et al. Cell Reports
- Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
- (2013) X. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- (2013) Tim Wang et al. SCIENCE
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities
- (2012) Rani Najdi et al. DIFFERENTIATION
- Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling
- (2012) Kyle D. Proffitt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How cancer metabolism is tuned for proliferation and vulnerable to disruption
- (2012) Almut Schulze et al. NATURE
- ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
- (2012) Huai-Xiang Hao et al. NATURE
- Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
- (2012) Bon-Kyoung Koo et al. NATURE
- Structural Basis of Wnt Recognition by Frizzled
- (2012) C. Y. Janda et al. SCIENCE
- Signaling in Control of Cell Growth and Metabolism
- (2012) P. S. Ward et al. Cold Spring Harbor Perspectives in Biology
- Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways
- (2011) J. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- (2010) Milind M Javle et al. BMC CANCER
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification
- (2010) G. S. Coombs et al. JOURNAL OF CELL SCIENCE
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation
- (2008) M. Wall et al. BLOOD
- Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started